Invesco Mutual Fund Raises Stake in Sahajanand Medical Technologies to 5.05%

Invesco Mutual Fund Raises Stake in Sahajanand Medical Technologies to 5.05%
Published on October 27, 2026|Author: Team Choice

Invesco Mutual Fund has acquired an additional stake in Sahajanand Medical Technologies Limited through open market transactions executed on October 23, 2026.

According to the regulatory disclosure, the fund acquired 44,20,453 equity shares, representing 4.3488% of the company's paid-up share capital.

Before the transaction, the fund held 7,17,682 shares, equivalent to 0.7061% of the company's share capital.

Following the acquisition, its aggregate holding increased to 51,38,135 shares, representing 5.0549% of the company's share capital.

The transaction took the fund's aggregate shareholding above the 5% threshold. The disclosure was submitted in accordance with SEBI's takeover regulations.

Invesco Mutual Fund Participating Schemes

The acquisition was disclosed across four schemes managed by Invesco Mutual Fund:

  • Invesco India Business Cycle Fund
  • Invesco India Flexi Cap Fund
  • Invesco India Pharma and Healthcare Fund
  • Invesco India Small Cap Fund

The reported 5.0549% holding represents the aggregate shareholding disclosed across the participating schemes, rather than an individual holding attributed to each scheme.

Sahajanand Medical Technologies Shareholding Highlights

  • Company: Sahajanand Medical Technologies Limited
  • Acquirer: Invesco Mutual Fund
  • Investment Manager: Invesco Asset Management (India) Private Limited
  • Transaction Type: Open market acquisition
  • Transaction Date: October 23, 2026
  • Disclosure Date: October 26, 2026
  • Shares Acquired: 44,20,453 equity shares
  • Stake Acquired: 4.3488%
  • Pre-Acquisition Holding: 7,17,682 shares, representing 0.7061%
  • Post-Acquisition Holding: 51,38,135 shares, representing 5.0549%
  • Acquisition Method: Open market
  • Applicable Regulation: Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
  • Stock Exchanges: BSE Limited and National Stock Exchange of India Limited
  • Participating Schemes: Invesco India Business Cycle Fund, Invesco India Flexi Cap Fund, Invesco India Pharma and Healthcare Fund, and Invesco India Small Cap Fund

What to Watch Next

  • Investors may monitor subsequent regulatory disclosures from Sahajanand Medical Technologies Limited and Invesco Mutual Fund for updates on institutional shareholding and changes in ownership.
  • The increase in Invesco Mutual Fund's aggregate holding above 5% is a regulatory disclosure of its shareholding position. The acquisition alone does not establish the fund's investment rationale or indicate its future investment intentions.
  • Market participants can also track BSE and NSE filings for further information regarding the company's shareholding structure and subsequent changes in institutional ownership.

Disclaimer

Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Registration granted by SEBI, and certification from NISM in no way guarantee the performance of the intermediary or provide any assurance of returns to investors. Choice Equity Broking Private Limited: SEBI Reg No. Broking - INZ000160131 ( BSE - 3299 ) | ( NSE - 13773 ) | ( MSEI - 73200 ) | ( MCX - 40585 ) | ( NCDEX - 01006 ). Depository Participant SEBI Reg. No. - IN - DP - 84 - 2015, DP ID CDSL - 12066900, NSDL ID - IN301895. Research Analyst - INH000000222 (CIN. NO.: U65999MH2010PTC198714)

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations

Other News

VA Tech Wabag Secures Mega Order from Reliance Industries for Jamnagar Desalination Plant

VA Tech Wabag Secures Mega Order from Reliance Industries for Jamnagar Desalination Plant

VA Tech Wabag Limited has secured a mega order from Reliance Industries Limited (RIL) for a desalination and remineralisation plant at Jamnagar, Gujarat. The project involves setting up a desalination facility with an initial capacity of 8,400 cubic metres per hour, expandable to 12,600 cubic metres per hour, along with a remineralisation plant. The project will be executed in phases over 25 months.

Irfan Chapra and Associates Announce 26% Open Offer for Hittco Tools

Irfan Chapra and Associates Announce 26% Open Offer for Hittco Tools

Irfan Ismail Chapra, Reshma Irfan Chapra and Mubina Gulzar Sofia have announced an open offer to acquire up to 58,77,261 equity shares of Hittco Tools Limited, representing 26.00% of the company's expanded share capital on a fully diluted basis. The open offer price has been fixed at Rs 15.30 per fully paid-up equity share and Rs 10.30 per partly paid-up equity share. The offer follows a proposed preferential allotment of equity shares and convertible warrants approved by the company's board of directors.

Tata Motors’ CV Arm Secures 89.42% Stake in Iveco Group Through Tender Offer

Tata Motors’ CV Arm Secures 89.42% Stake in Iveco Group Through Tender Offer

TML CV Holdings B.V., a subsidiary of Tata Motors, has received acceptances for 238.16 million common shares of Iveco Group N.V. under its voluntary tender offer. The shares represent 89.42% of Iveco’s common share capital, excluding treasury shares, allowing the offer to meet its threshold condition. The total consideration for the accepted shares stands at approximately €3.43 billion, with payment scheduled for October 30, 2026.